Showing results (2141-2150 of 3,641) with videos related to

Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|March 26, 2025
Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2- metastatic breast cancer: A Flatiron Health database analysisRachel M Layman, Xianchen Liu, Benjamin Li, et al.
Breast (Edinburgh, Scotland)|March 11, 2025
The relationship between decision regret, quality of life, and mindfulness in early-stage breast cancer survivorsYu-Ling Kao, Ming-Shen Dai, Wan-Chen Tsai, et al.
Breast (Edinburgh, Scotland)|March 9, 2025
Awareness of genomic testing among patients with breast cancer in EuropeAntonella Cardone, Dany Bell, Conchi Biurrun, et al.
Breast (Edinburgh, Scotland)|April 8, 2025
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative reviewJavier Muñoz, Sabrina Nucera, Nuria Rubira Garcia, et al.
Breast (Edinburgh, Scotland)|December 19, 2024
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration dataDan-Dan Tang, Zhuo-Jun Ye, Wan-Wan Liu, et al.
Breast (Edinburgh, Scotland)|December 1, 2024
Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysisMaria Inez Dacoregio, Isabella Michelon, Caio Ernesto do Rego Castro, et al.
Breast (Edinburgh, Scotland)|December 3, 2024
Adipocyte heterogeneity and tumor infiltration of adipose tissue in patients with metastatic breast cancerHava Izci, Gitte Zels, Anirudh Pabba, et al.
Breast (Edinburgh, Scotland)|December 15, 2024
General obesity, abdominal obesity, and the risk of cardiovascular disease including stroke in 5-year breast cancer survivorsJi Soo Kim, Jihun Song, Seulggie Choi, et al.
Breast (Edinburgh, Scotland)|December 24, 2024
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find themL Foffano, L Cucciniello, E Nicolò, et al.
Breast (Edinburgh, Scotland)|November 9, 2024
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 studyAlfonso Cortés, Elena López-Miranda, Adela Fernández-Ortega, et al.
Pageof 365